Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taoqian Zhao

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetryTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Tricyclic KRAS Inhibitors for the Treatment of CancerTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular DisordersTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational MedicineTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Enhancing the Stability of <sup>211</sup>At Radiopharmaceuticals: Insights from Ortho-Substituent StrategiesTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Multivalent FAPI-based radiopharmaceuticals in PET/CT: from cancer diagnostics to theranosticsTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementiasTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Development of Bicyclic Compounds Containing a Tertiary Amine Moiety as T Cell ActivatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Thieno[3,2‑<i>b</i>]Pyridine Derivatives in the Treatment of Huntington's DiseaseTaoqian Zhao, Steven H Liang
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetryTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Tricyclic KRAS Inhibitors for the Treatment of CancerTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular DisordersTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational MedicineTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Enhancing the Stability of <sup>211</sup>At Radiopharmaceuticals: Insights from Ortho-Substituent StrategiesTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Multivalent FAPI-based radiopharmaceuticals in PET/CT: from cancer diagnostics to theranosticsTaoqian Zhao, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementiasTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Development of Bicyclic Compounds Containing a Tertiary Amine Moiety as T Cell ActivatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Thieno[3,2‑<i>b</i>]Pyridine Derivatives in the Treatment of Huntington's DiseaseTaoqian Zhao, Steven H Liang
Pageof 3